Related Experiment Video
Updated: Apr 23, 2026
Human Blastocyst Biopsy and Vitrification
Published on: July 26, 2019
Blastocentesis: a source of DNA for preimplantation genetic testing. Results from a pilot study
Luca Gianaroli1, M Cristina Magli1, Alessandra Pomante1
1Reproductive Medicine Unit, Società Italiana Studi di Medicina della Riproduzione, Bologna, Italy.
Objective:
To investigate the presence of DNA in blastocyst fluids (BFs) and to estimate whether the chromosomal status predicted by its analysis corresponds with the ploidy condition in trophectoderm (TE) cells, the whole embryo, and that predicted by polar bodies (PBs) or blastomeres.
Design:
Prospective study.
Setting:
In vitro fertilization unit.
Patient(S):
Seventeen couples undergoing preimplantation genetic screening with the use of array comparative genomic hybridization on PBs (n = 12) or blastomeres (n = 5).
Intervention(S):
BFs and TE cells were retrieved from 51 blastocysts for separate chromosomal analysis.
Main Outcome Measure(S):
Presence of DNA in BFs and assessment of the corresponding chromosome condition; correlation with the results in TE cells and those predicted by the analysis done at earlier stages.
Result(S):
DNA was detected in 39 BFs (76.5%). In 38 of 39 cases (97.4%) the ploidy condition of BFs was confirmed in TE cells, and the rate of concordance per single chromosome was 96.6% (904/936). In relation to the whole embryo, the ploidy condition corresponded in all cases with a per-chromosome concordance of 98.1%. The testing of PBs and blastomeres had 93.3% and 100% prediction of BF ploidy condition with a concordance per chromosome of 93.5% and 94%, respectively.
Conclusion(S):
Blastocentesis could represent an alternative source of material for chromosomal testing, because the BF is highly predictive of the embryo ploidy condition and chromosome content. Our data confirm the relevance of the oocyte and of the early-cleavage embryo in determining the ploidy condition of the resulting blastocyst.
